Rankiteo Logo
Rankiteo

The Rankiteo MCP server is now available.

Discover MCP
!

Top 25 Worst Pharmaceutical Manufacturing Companies

Identify the lowest-scoring most renowned Pharmaceutical Manufacturing companies. Understand where critical cyber risk exposure exists in this industry. 304 companies scored.

1,107
Companies in Industry
304
Scored
757.3
Avg Score
45
Cyber Incidents
Bottom 25
Shown

Pharmaceutical Manufacturing Cybersecurity Risk Assessment - Lowest-Scoring Companies in 2026

Out of 1,107 pharmaceutical manufacturing companies monitored by Rankiteo, this page highlights the Bottom 25 organizations with the weakest cybersecurity posture. These rankings are based on our proprietary Cyber Resilience Score, which integrates time-decayed incident exposure, sector-sensitive impact analysis, and market-cap-aware baseline and dampening to produce a single, interpretable score between 100 and 1,000.

Companies at the bottom of this ranking carry the heaviest accumulated cyber incident burden - including recent or severe ransomware attacks, data breaches with significant financial losses or records exposed, and repeated disclosure events. Their scores are further influenced by sector-specific impact multipliers that amplify penalties in high-criticality industries. Understanding where these risk concentrations exist is essential for supply chain risk management, regulatory compliance, and competitive benchmarking within the pharmaceutical manufacturing industry.

The current average score for the most renowned Pharmaceutical Manufacturing companies is 757.3 out of 1,000. Companies shown below score significantly lower than this average, falling far behind an industry that generally maintains reasonable security standards.

Risk Highlights

749
Lowest Score
757.3
Industry Average
4%
Scoring B or Below
45
Recorded Incidents
AI Analysis

Cyber Risk in Pharmaceutical Manufacturing

Generating industry analysis...

Score Distribution

Aaa
0 (0.0%)
Aa
0 (0.0%)
A
20 (6.6%)
Baa
254 (83.6%)
Ba
17 (5.6%)
B
7 (2.3%)
Caa
4 (1.3%)
Ca
1 (0.3%)
C
1 (0.3%)
#CompanyLabelScoreBandIncidentsScore Bar
1
Octapharma Plasma, Inc.octapharmaplasma.com
Pharmaceutical and Medicine Manufacturing375C3
2
ExecuPharmexecupharm.com
Pharmaceutical and Medicine Manufacturing597Ca1
3
Amarin Corporationamarincorp.com
Pharmaceutical and Medicine Manufacturing633Caa2
4
Eisai Co., Ltd.eisai.com
Pharmaceutical and Medicine Manufacturing641Caa1
5
BioPlus Specialty Pharmacybioplusrx.com
Pharmaceutical and Medicine Manufacturing649Caa3
6
PharMericapharmerica.com
Pharmaceutical and Medicine Manufacturing649Caa2
7
PCCApccarx.com
Pharmaceutical and Medicine Manufacturing657B2
8
Merck Groupmerckgroup.com
Pharmaceutical and Medicine Manufacturing663B1
9
QPharma, Inc.qpharmacorp.com
Pharmaceutical and Medicine Manufacturing680B1
10
Envision Pharma Groupenvisionpharmagroup.com
Pharmaceutical and Medicine Manufacturing681B1
11
Chiesi USA, Inc.chiesiusa.com
Pharmaceutical and Medicine Manufacturing682B1
12
Pii, A Jabil Companypharm-int.com
Pharmaceutical and Medicine Manufacturing694B1
13
Cambrexcambrex.com
Pharmaceutical and Medicine Manufacturing697B1
14
Oraoraclinical.com
Pharmaceutical and Medicine Manufacturing703Ba1
15
Acadia Pharmaceuticals Inc.acadia.com
Pharmaceutical and Medicine Manufacturing706Ba1
16
BioLife Plasma Servicesbiolifeplasma.com
Pharmaceutical and Medicine Manufacturing710Ba1
17
Advarraadvarra.com
Pharmaceutical and Medicine Manufacturing713Ba1
18
Taro Pharmaceuticalstaro.com
Pharmaceutical and Medicine Manufacturing716Ba1
19
Lachman Consultant Serviceslachmanconsultants.com
Pharmaceutical and Medicine Manufacturing721Ba1
20
EVERSANAeversana.com
Pharmaceutical and Medicine Manufacturing732Ba1
21
Lash Grouplashgroup.com
Pharmaceutical and Medicine Manufacturing737Ba2
22
Eisai USeisai.com
Pharmaceutical and Medicine Manufacturing745Ba1
23
Pierre Fabre Laboratoriespierre-fabre.com
Pharmaceutical and Medicine Manufacturing747Ba1
24
TherapeuticsMDtherapeuticsmd.com
Pharmaceutical and Medicine Manufacturing748Ba0
25
Alliance Healthcarealliance-healthcare.com
Pharmaceutical and Medicine Manufacturing749Ba1

How Cyber Risk Scores Are Calculated

Rankiteo's Cyber Resilience Score produces a single value between 100 and 1,000 for each organization, where higher scores indicate lower estimated cyber risk. The framework integrates three principal components that together balance evidence, context, and comparability across industries and company sizes. Learn more in our AI Cyber Score methodology.

Core Scoring Components

  • Time-Decayed Incident Exposure (Pinc): Every confirmed cyber incident - ransomware, data breach, cyber attack, or disclosed vulnerability - contributes a penalty weighted by recency and scaled by quantitative severity (financial loss and records exposed). Category-specific base weights reflect real-world impact: ransomware (100 pts), data breach (60 pts), cyber attack (20 pts), and vulnerability (5 pts). Each category decays at a different rate - roughly 3 years for ransomware and data breaches, 2 years for cyber attacks, and 18 months for vulnerabilities - so older, lower-impact events fade while recent, severe incidents retain lasting influence.
  • Sector-Sensitive Impact Multipliers: Identical incidents carry different weight depending on the industry. Each NAICS sector receives multipliers based on four dimensions: safety-of-life risk, service continuity, regulatory/legal exposure, and data sensitivity. A ransomware attack on a hospital or utility carries a higher penalty than the same attack on a retail company, reflecting the greater real-world consequences.
  • Market-Cap Baseline & Dampening: A logistic baseline between 750 and 850 anchors each company's starting score based on organizational size. A continuous dampening factor attenuates incident penalties for very large firms, recognizing higher disclosure rates and greater absorption capacity - without masking genuinely severe events.
  • Industry Adjustment (Aind): A bounded additive term derived from NAICS-level historical incident-rate z-scores. This rewards companies in historically resilient sectors, but only when they maintain a clean or near-clean record. Once material incidents occur, firm-specific performance dominates.
  • Quantitative Severity Scaling: When financial loss or records-exposed data is available, incident penalties are amplified proportionally - scaled relative to market capitalization so the same dollar loss has a larger effect on a smaller firm. The combined severity multiplier caps at 3×.
  • Ransomware Recurrence Escalation: Repeated ransomware events trigger a bounded recurrence multiplier (up to 1.5×), reflecting elevated systemic risk from persistent adversarial footholds or remediation failures.

Understanding the Risk Bands

Each score maps to a letter-grade band. Companies appearing in this lowest-scoring ranking typically fall in the bottom bands:

  • Aaa (900–1,000): Exceptional cyber resilience - very few companies in a worst list reach this level.
  • Aa (800–899): Very strong security posture with minimal weaknesses.
  • A (700–799): Strong practices with some areas for improvement.
  • Baa (600–699): Adequate protection but notable security configuration gaps exist.
  • Ba (500–599): Below average - multiple risk areas require attention.
  • B (400–499): Weak security with significant exposure across categories.
  • Caa (300–399): Very weak with a high probability of exploitable vulnerabilities.
  • Ca (200–299): Critically poor with severe, widespread security gaps.
  • C (0–199): Extreme risk - immediate remediation is needed across all dimensions.

Why Monitoring Low-Scoring Pharmaceutical Manufacturing Companies Matters

Cybersecurity risk doesn't exist in isolation. If your organization works with, purchases from, or shares data with companies in the pharmaceutical manufacturing sector, their security weaknesses become your risk. Supply chain attacks - where adversaries compromise a less-secure vendor to reach a larger target - have become one of the most common and damaging attack vectors in recent years.

By identifying the lowest-scoring pharmaceutical manufacturing companies, procurement teams, risk managers, CISOs, and compliance officers can:

  • Flag third-party vendors that may introduce unacceptable risk into the supply chain.
  • Require cybersecurity improvement plans as part of vendor management and contract renewal processes.
  • Benchmark their own organization against industry peers and understand where the floor lies.
  • Satisfy regulatory due-diligence requirements such as those mandated by NIS2, DORA, SOC 2, and ISO 27001 supply chain provisions.

Rankiteo continuously monitors 1,107 pharmaceutical manufacturing companies keeping these rankings up to date so you always have an accurate, current picture of the sector's risk landscape.

Top 25 Worst Pharmaceutical Manufacturing Companies by Cybersecurity Score (2026) | Rankiteo | Rankiteo